Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002).
The British Society of Gastroenterology (BSG) and the Association of Coloproctology for Great Britain and Ireland (ACPGBI) commissioned this update of the 2002 guidance. The aim, as before, is to provide guidance on the appropriateness, method and frequency of screening for people at moderate and high risk from colorectal cancer. This guidance provides some new recommendations for those with inflammatory bowel disease and for those at moderate risk resulting from a family history of colorectal cancer. In other areas guidance is relatively unchanged, but the recent literature was reviewed and is included where appropriate.
Cairns
Stuart R
SR
Digestive Diseases Centre, Brighton and Sussex University Hospitals, Royal Sussex County Hospital, Eastern Road, Brighton, UK. Stuart.cairns@bsuh.nhs.uk
Scholefield
John H
JH
Steele
Robert J
RJ
Dunlop
Malcolm G
MG
Thomas
Huw J W
HJ
Evans
Gareth D
GD
Eaden
Jayne A
JA
Rutter
Matthew D
MD
Atkin
Wendy P
WP
Saunders
Brian P
BP
Lucassen
Anneke
A
Jenkins
Paul
P
Fairclough
Peter D
PD
Woodhouse
Christopher R J
CR
D000172:Acromegaly / Q000150:complications; D000236:Adenoma / Q000175:diagnosis; D000714:Anastomosis, Surgical / Q000009:adverse effects; D012809:Colon, Sigmoid / Q000601:surgery; D003113:Colonoscopy / Q000379:methods / Q000592:standards; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000209:etiology / Q000601:surgery; D055088:Early Detection of Cancer / Q000379:methods* / Q000592:standards; D019317:Evidence-Based Medicine / Q000379:methods; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications; D009386:Neoplastic Syndromes, Hereditary / Q000175:diagnosis; D011159:Population Surveillance / Q000379:methods; D013222:State Medicine / Q000592:standards; D014513:Ureter / Q000601:surgery